| Affymax and Takeda Announce the Submission of a New Drug Application for ... - Gamut News |
|
|
Gamut News “Anemia is a debilitating condition for chronic renal failure patients on dialysis, and our program illustrates the potential of peginesatide as an important once-monthly therapeutic option for patients and providers, if approved. ... Affymax Submits NDA For Peginesatide RTT News Affymax, Takeda Pharma file peginesatide NDA Pharmaceutical Business Review Affymax and Takeda Announce the Submission of a New Drug Application for |